zepbound glp 1 or 2 Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type diabetes, a large retrospective cohort GLP-1 medications are everywhere right
Description
In the cohorts we adjusted for age, sex, marital status, education, physical and psychiatric comorbidity registered within 10 years before the index date
In line with the latter, GLP-1 have been shown to protect from ischaemia/reperfusion injuries in isolated perfused rat hearts (Bose et al., 2005)
With supplement brands and social media hyping up patch-based options, its crucial to know whats backed by science and whats just marketing talk
Livesey G, Taylor R, Livesey HF, Buyken AE, Jenkins DJA, Augustin LSA, et al
They demonstrate a commendable safety record, a low incident rate of hypoglycemia, and negligible side effects
